title: Chronic congestive heart failure - a new therapeutic choice.
authors.affiliation: Division of Cardiology, Department of Medicine (Parker), Mount Sinai Hospital; Division of Cardiology, Department of Medicine (Parker, Ross), University Health Network Hospitals; Lunenfeld-Tanenbaum Research Institute (Parker); Peter Munk Cardiac Centre (Parker, Ross), Toronto General Hospital, Toronto, Ont. john.parker@uhn.ca.
authors.forename: John D
authors.initials: JD
authors.lastname: Parker
authors.affiliation: Division of Cardiology, Department of Medicine (Parker), Mount Sinai Hospital; Division of Cardiology, Department of Medicine (Parker, Ross), University Health Network Hospitals; Lunenfeld-Tanenbaum Research Institute (Parker); Peter Munk Cardiac Centre (Parker, Ross), Toronto General Hospital, Toronto, Ont.
authors.forename: Heather J
authors.initials: HJ
authors.lastname: Ross
mesh_terms: D000613:Aminobutyrates / Q000008:administration & dosage / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001713:Biphenyl Compounds; D002170:Canada; D002908:Chronic Disease; D004338:Drug Combinations; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D013777:Tetrazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D000068756:Valsartan / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000613:Aminobutyrates; D000806:Angiotensin-Converting Enzyme Inhibitors; D001713:Biphenyl Compounds; D004338:Drug Combinations; D013777:Tetrazoles; D000068756:Valsartan; C549068:sacubitril and valsartan sodium hydrate drug combination